Invitation to Roche ’s virtual event at the 2022 ASCO Annual Meeting focusing on the oncology pipeline

We are pleased to invite investors and analysts to participate in our virtual event onMonday,  6 June 2022, highlighting Roche data presented during the congress scientific program from June 3 – 7 2022 and our early-stage oncology portfolio.16:00 – 17:30 CEST / 15:00 - 16:30 BST09:00 – 10:30 am CDT / 7:00 – 8:30 am PDT The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:00 CEST on the day of the event. >click hereAccess to virtual event (pre-registration required)Please pre-register for our webinarhere*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail [e-mail]. A replay of the webcast will be available via>ir.roche.com *privacy noticeBest regards, Bruno Eschli Head of Investor RelationsSabine Borngr äberInvestor Relations Officer  Roche Investor Relations Dr. Bruno EschliPhone: [phone]e-mail:[e-mail] Dr. Sabine Borngr äberPhone: [phone]e-mail:[e-mail] Dr. Birgit MasjostPhone: [phone]e-mail:[e-mail] Dr. Gerard TobinPhone: [phone]e-mail:[e-mail]   Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail]  

Source: Roche Investor Update - May 6, 2022 Category: Pharmaceuticals Source Type: news